
Modafinil (Provigil)
From PsychRounds: The Psychiatry Podcast by Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller
June 3, 2026 · 20 min
About this episode
This episode explores the nuanced use of Modafinil in psychiatry.
Welcome back! Today, we are looking at Modafinil and it's nuanced use in psychiatry. References: Provigil (modafinil) [prescribing information]. North Wales, PA: Teva Pharmaceuticals USA, Inc. U.S. Food and Drug Administration. Available at: https://www.accessdata.fda.gov/drugsatfda docs/label/2015/020717s037s038lbl.pdf Schwartz JR. Modafinil in the treatment of excessive sleepiness. Drug Des Devel Ther. 2009;2:71–85. Kaplan S, Goehring EL Jr, Engel T, et al. Cardiovascular outcomes associated with modafinil in patients with obstructive sleep apnea. Pharmacoepidemiol Drug Saf. 2018;27(11):1182–1190. doi:10.1002/pds.4642 Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727–738. doi:10.1016/S2215-0366(18)30269-4 Goss AJ, Kaser M, Costafreda SG, Sahakian BJ, Fu CH. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry. 2013;74(11):1101–1107. doi:10.4088/JCP.13r08560 Bahji A…
People in this episode
Hosts: Dr. Tanner Hewitt, Dr. Larry Wang, Dr. Bradley Miller
Topics covered
- Modafinil
- psychiatry
- sleep disorders
- ADHD
- depression
- treatment efficacy
Keywords
- Modafinil
- Provigil
- psychiatry
- sleepiness
- ADHD
- depression
- treatment
Mentioned in this episode
Organizations: Teva Pharmaceuticals USA, Inc., U.S. Food and Drug Administration
Products: Modafinil
Books & works: Drug Des Devel Ther, Lancet Psychiatry, J Clin Psychiatry, J Affect Disord
More episodes of PsychRounds: The Psychiatry Podcast
- Naltrexone · May 20, 2026 · 16 min
- Placebo Effect and Response in Psychiatry · May 6, 2026 · 22 min
- Amantadine (Symmetrel) · April 8, 2026 · 17 min
- VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo) · March 21, 2026 · 17 min
- A DSM Conversation with Dr. Allen Frances · February 25, 2026 · 56 min
- Topiramate (Topamax) · January 28, 2026 · 15 min
Explore listener stats, chart rankings, contacts and more on the PsychRounds: The Psychiatry Podcast podcast page.